0000899243-22-007029.txt : 20220218 0000899243-22-007029.hdr.sgml : 20220218 20220218163044 ACCESSION NUMBER: 0000899243-22-007029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220216 FILED AS OF DATE: 20220218 DATE AS OF CHANGE: 20220218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VAN BEEK JEROEN B CENTRAL INDEX KEY: 0001743662 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39409 FILM NUMBER: 22653260 MAIL ADDRESS: STREET 1: C/O TRICIDA, INC. STREET 2: 7000 SHORELINE COURT, SUITE 201 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allovir, Inc. CENTRAL INDEX KEY: 0001754068 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 831971007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (617) 433-2605 MAIL ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: ViraCyte, Inc. DATE OF NAME CHANGE: 20180924 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-16 0 0001754068 Allovir, Inc. ALVR 0001743662 VAN BEEK JEROEN B C/O ALLOVIR, INC. 1100 WINTER STREET WALTHAM MA 02451 0 1 0 0 Chief Commercial Officer Common Stock 2022-02-16 4 S 0 15322 8.323 D 382900 D Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.15 to $8.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. /s/ Brett Hagen, as Attorney-in-Fact 2022-02-18